Literature DB >> 14736548

Estrogen replacement therapy reverses changes in intramural coronary resistance arteries caused by female sex hormone depletion.

Metin Mericli1, György L Nádasy, Maria Szekeres, Szabolcs Várbíró, Zoltan Vajo, Máté Mátrai, Nándor Acs, Emil Monos, Béla Székács.   

Abstract

OBJECTIVE: We tested the hypothesis that female sex hormone depletion and estradiol replacement therapy significantly influences the biomechanical properties of intramural coronary resistance arteries.
DESIGN: Female rats (n=30) were divided into three groups. In group O, rats were subjected to bilateral ovariectomy. Group HRT was subjected to bilateral ovariectomy and estradiol replacement therapy. Rats in group C served as controls. One month after ovariectomy, intramural coronary arteries (approximately 200 microm in diameter) branching from the left anterior descending coronary were isolated, cannulated and studied by microarteriography. Intraluminal pressure was increased in steps between 0 and 90 mm Hg. The steady state diameter at each step was measured. These measurements were repeated in the presence of U46619, a thromboxane (TX) A2 receptor agonist (at a concentration of 10(-6) M), and bradykinin (BK; at 10(-6) M). Finally, Ca2+-free Krebs-induced passive diameter (PD) was measured in each group.
RESULTS: Ovariectomy increased spontaneous myogenic tone of coronary arteries (p<0.05), which was normalized by estrogen replacement. Ovariectomy decreased distensibility observed at low pressure, although passive diameter was not changed. Estrogen replacement decreased wall stress and elastic modulus (p<0.05). The thromboxane A2 agonist induced the largest contraction in the ovariectomized group, whereas bradykinin-induced relaxation was the largest in the estrogen replacement group (p<0.05).
CONCLUSION: Estradiol hormone replacement therapy (HRT) may exert a beneficial effect on myocardial perfusion in menopause by opposing the deterioration of biomechanical properties of intramural coronary resistance vessels induced by female sex hormone depletion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736548     DOI: 10.1016/j.cardiores.2003.11.022

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Effects of sex on coronary microvascular dysfunction and cardiac outcomes.

Authors:  Venkatesh L Murthy; Masanao Naya; Viviany R Taqueti; Courtney R Foster; Mariya Gaber; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Ornella Rimoldi; Paolo G Camici; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-04-30       Impact factor: 29.690

2.  Remodeling of Wall Mechanics and the Myogenic Mechanism of Rat Intramural Coronary Arterioles in Response to a Short-Term Daily Exercise Program: Role of Endothelial Factors.

Authors:  Mária Szekeres; György L Nádasy; Gabriella Dörnyei; Annamária Szénási; Akos Koller
Journal:  J Vasc Res       Date:  2018-02-14       Impact factor: 1.934

3.  Prenatal cocaine exposure causes sex-dependent impairment in the myogenic reactivity of coronary arteries in adult offspring.

Authors:  DaLiao Xiao; Shumei Yang; Lubo Zhang
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

Review 4.  Coronary microvascular dysfunction pathophysiology in COVID-19.

Authors:  Jie Yin; Shaoshen Wang; Yang Liu; Junhong Chen; Dongye Li; Tongda Xu
Journal:  Microcirculation       Date:  2021-06-02       Impact factor: 2.679

Review 5.  Cardiovascular Imaging for Ischemic Heart Disease in Women: Time for a Paradigm Shift.

Authors:  Patricia F Rodriguez Lozano; Elona Rrapo Kaso; Jamieson M Bourque; Mohamed Morsy; Angela M Taylor; Todd C Villines; Christopher M Kramer; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2022-03-16

6.  Estrogen therapy may counterbalance eutrophic remodeling of coronary arteries and increase bradykinin relaxation in a rat model of menopausal hypertension.

Authors:  Mate Matrai; Judit R Hetthéssy; Gyorgy L Nadasy; Bela Szekacs; Metin Mericli; Nandor Acs; Emil Monos; Nissim Arbib; Szabolcs Varbiro
Journal:  Menopause       Date:  2016-07       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.